Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.

[1]  D. Cibula.  Early-stage intermediate-risk—the group with the most heterogenous management among patients with cervical cancer , 2022, International Journal of Gynecological Cancer.

[2]  G. Scambia,et al.  CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16) , 2022, International Journal of Gynecological Cancer.

[3]  R. Pareja,et al.  Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update? , 2022, International Journal of Gynecological Cancer.

[4]  F. Landoni,et al.  The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. , 2021, European journal of cancer.

[5]  M. Morgan,et al.  Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors , 2021, International Journal of Gynecological Cancer.

[6]  Zheng Feng,et al.  Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer , 2020, International Journal of Gynecological Cancer.

[7]  H. Yagi,et al.  Is Adjuvant Therapy Necessary for Patients with Intermediate-Risk Cervical Cancer after Open Radical Hysterectomy? , 2020, Oncology.

[8]  A. Ayhan,et al.  Comparison of no adjuvant treatment and radiotherapy in early‐stage cervical carcinoma with intermediate risk factors , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  J. Cueva,et al.  SEOM clinical guidelines for cervical cancer (2019) , 2020, Clinical and Translational Oncology.

[10]  H. Westerveld,et al.  Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy , 2019, International Journal of Gynecological Cancer.

[11]  J. Berek,et al.  Revised FIGO staging for carcinoma of the cervix uteri , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  L. Dušek,et al.  Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature. , 2018, Gynecologic oncology.

[13]  E. Åvall-Lundqvist,et al.  ESGO Survey on Current Practice in the Management of Cervical Cancer , 2018, International Journal of Gynecologic Cancer.

[14]  R. Pötter,et al.  The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  D. Cibula,et al.  2017 Update on the Querleu–Morrow Classification of Radical Hysterectomy , 2017, Annals of Surgical Oncology.

[16]  H. Dickinson,et al.  Radiotherapy and chemoradiation after surgery for early cervical cancer. , 2012, The Cochrane database of systematic reviews.

[17]  R. Zaino,et al.  A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. , 2006, International journal of radiation oncology, biology, physics.

[18]  A. Peters,et al.  Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study , 2005, International Journal of Gynecologic Cancer.

[19]  B N Bundy,et al.  A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. , 1999, Gynecologic oncology.

[20]  K. Bilek,et al.  Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study. , 1982, Archiv fur Geschwulstforschung.